
pmid: 4513058
To the Editor.— The statement by Hinkes and Plotkin (223:1490, 1973) that "perhaps 0.1% to 1% of patients with acute leukemia survive five or more years" gives an erroneously bleak outlook. No longer is the fiveyear survivor a rarity. Recently, Ingelfinger quoted the Director of the National Cancer Institute who said that "50 per cent of children with acute lymphocytic leukemia (who get) optimal treatment survive at least five years today. Tragically, only 15 per cent of the children afflicted get optimal treatment." 1 In an editorial reply, the Chairman of the Acute Leukemia Group B (ALGB) indicated that the ALGB data support the contention that "50 per cent of children now under optimal treatment as it is known today should survive for at least five years." 2 The directions in abbreviated form for such optimal treatment were then appended. 2 The experience of ALGB is not unique. Other cancer cooperative
Time Factors, Age Factors, Humans, Child, Leukemia, Lymphoid
Time Factors, Age Factors, Humans, Child, Leukemia, Lymphoid
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
